Compare Stocks

Date Range: 

 Oncternal TherapeuticsImmunomeSernovaWave Life SciencesiBio
SymbolNASDAQ:ONCTNASDAQ:IMNMOTCMKTS:SEOVFNASDAQ:WVENYSEAMERICAN:IBIO
Price Information
Current Price$5.56$21.98$1.14$6.08$1.61
52 Week RangeBuyBuyN/ABuyBuy
MarketRank™
Overall Score1.71.00.51.81.3
Analysis Score4.51.50.03.33.5
Community Score3.33.02.72.63.1
Dividend Score0.00.00.00.00.0
Ownership Score0.00.00.02.50.0
Earnings & Valuation Score0.60.60.00.60.0
Analyst Ratings
Consensus RecommendationBuyBuyN/ABuyBuy
Consensus Price Target$15.20$18.00N/A$11.80$2.50
% Upside from Price Target173.38% upside-18.11% downsideN/A94.08% upside55.28% upside
Trade Information
Market Cap$274.46 million$234.31 million$294.20 million$303.12 million$347.78 million
Beta1.66N/A1.460.35-5.81
Average Volume1,625,255237,177133,426823,14113,924,231
Sales & Book Value
Annual Revenue$2.42 millionN/AN/A$15.98 million$1.64 million
Price / Sales113.41N/AN/A18.97212.06
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$0.93 per shareN/A$0.02 per share$1.86 per share$0.48 per share
Price / Book5.98N/AN/A3.273.35
Profitability
Net Income$-34,190,000.00$-10,440,000.00$-2,990,000.00$-193,640,000.00$-16,440,000.00
EPS($1.56)N/AN/A($5.72)N/A
Trailing P/E RatioN/A0.00N/AN/A0.00
Forward P/E RatioN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-746.10%N/AN/A-1,562.01%-1,005.62%
Return on Equity (ROE)-150.58%N/A-195.56%-401.32%-55.71%
Return on Assets (ROA)-91.87%N/A-151.94%-72.82%-26.91%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/A0.46%N/A0.40%
Current Ratio3.01%1.38%2.29%1.33%16.84%
Quick Ratio3.01%1.38%2.29%1.33%16.67%
Ownership Information
Institutional Ownership Percentage10.79%N/AN/A80.67%8.78%
Insider Ownership Percentage10.90%N/AN/A38.20%1.00%
Miscellaneous
Employees1223N/A30143
Shares Outstanding49.36 million10.66 million258.07 million49.86 million216.01 million
Next Earnings Date8/5/2021 (Estimated)6/24/2021 (Estimated)6/24/2021 (Estimated)5/13/2021 (Confirmed)5/21/2021 (Estimated)
OptionableNot OptionableNot OptionableNot OptionableOptionableNot Optionable
SourceHeadline
Thinking about buying stock in iBio, T2 Biosystems, Viewray, GoPro, or Tilray? | National | troyrecord.com - Troy RecordThinking about buying stock in iBio, T2 Biosystems, Viewray, GoPro, or Tilray? | National | troyrecord.com - Troy Record
troyrecord.com - May 8 at 8:58 PM
Heres Why iBio Stock Surged Friday - Motley FoolHere's Why iBio Stock Surged Friday - Motley Fool
fool.com - May 8 at 10:57 AM
Heres Why iBio Stock Surged FridayHere's Why iBio Stock Surged Friday
finance.yahoo.com - May 8 at 10:57 AM
Health Care Sector Update for 05/07/2021: ACST,ACST.V,IBIO,ORPH - NasdaqHealth Care Sector Update for 05/07/2021: ACST,ACST.V,IBIO,ORPH - Nasdaq
nasdaq.com - May 8 at 1:52 AM
Health Care Sector Update for 05/07/2021: ACST,ACST.V,IBIO,ORPH - NasdaqHealth Care Sector Update for 05/07/2021: ACST,ACST.V,IBIO,ORPH - Nasdaq
nasdaq.com - May 8 at 1:52 AM
(5/7/2021) IBIO Stock Has 64% Chance Of A Decline Over The Next Month After Rising 23% In The Last 5 Days. One-Month Expected Return For The Stock Is 11.7% - Trefis(5/7/2021) IBIO Stock Has 64% Chance Of A Decline Over The Next Month After Rising 23% In The Last 5 Days. One-Month Expected Return For The Stock Is 11.7% - Trefis
trefis.com - May 8 at 1:52 AM
(5/7/2021) IBIO Stock Has 64% Chance Of A Decline Over The Next Month After Rising 23% In The Last 5 Days. One-Month Expected Return For The Stock Is 11.7% - Trefis(5/7/2021) IBIO Stock Has 64% Chance Of A Decline Over The Next Month After Rising 23% In The Last 5 Days. One-Month Expected Return For The Stock Is 11.7% - Trefis
trefis.com - May 8 at 1:52 AM
Pre-Open Stock Movers 05/07: (IBIO) (BILL) (AXON) Higher; (CCIX) (APPN) (FROG) Lower (more...) - StreetInsider.comPre-Open Stock Movers 05/07: (IBIO) (BILL) (AXON) Higher; (CCIX) (APPN) (FROG) Lower (more...) - StreetInsider.com
streetinsider.com - May 7 at 3:36 PM
iBio – IBIO-202 - Genetic Engineering & Biotechnology NewsiBio – IBIO-202 - Genetic Engineering & Biotechnology News
genengnews.com - May 7 at 10:36 AM
Thinking about buying stock in Chiasma, Athenex, iBio, BioLineRx, or Endra Life Sciences? - Troy RecordThinking about buying stock in Chiasma, Athenex, iBio, BioLineRx, or Endra Life Sciences? - Troy Record
troyrecord.com - May 7 at 7:39 AM
iBio Stock Is Trading Higher After Announcing Next-Gen COVID-19 Vaccine Candidate - BenzingaiBio Stock Is Trading Higher After Announcing Next-Gen COVID-19 Vaccine Candidate - Benzinga
benzinga.com - May 7 at 7:39 AM
Why iBio Inc (IBIO) stock surged in the after-hours on Thursday? - Market GlobalistWhy iBio Inc (IBIO) stock surged in the after-hours on Thursday? - Market Globalist
marketglobalist.com - May 7 at 12:02 AM
iBio Reports Successful COVID-19 Vaccine Toxicology Study - GlobeNewswireiBio Reports Successful COVID-19 Vaccine Toxicology Study - GlobeNewswire
globenewswire.com - May 6 at 7:38 PM
iBio shares surge on COVID-19 study update - Seeking AlphaiBio shares surge on COVID-19 study update - Seeking Alpha
seekingalpha.com - May 6 at 7:02 PM
iBio, Inc. (IBIO) Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program - StreetInsider.comiBio, Inc. (IBIO) Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program - StreetInsider.com
streetinsider.com - May 6 at 4:38 PM
iBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program - BenzingaiBio Reports Successful COVID-19 Vaccine Toxicology Study Results and Announces Next-Gen COVID-19 Vaccine Program - Benzinga
benzinga.com - May 6 at 4:38 PM
Brokers Issue Forecasts for iBio, Inc.s FY2022 Earnings (NYSEAMERICAN:IBIO)Brokers Issue Forecasts for iBio, Inc.'s FY2022 Earnings (NYSEAMERICAN:IBIO)
americanbankingnews.com - May 6 at 11:16 AM
Premarket Mover: Ibio Inc (IBIO) Up 16.89% - InvestorsObserverPremarket Mover: Ibio Inc (IBIO) Up 16.89% - InvestorsObserver
investorsobserver.com - May 6 at 9:01 AM
iBio and Fraunhofer USA Conclude Litigation and Enter License Agreement - Yahoo FinanceiBio and Fraunhofer USA Conclude Litigation and Enter License Agreement - Yahoo Finance
finance.yahoo.com - May 6 at 4:00 AM
Why iBio Stock Soared Today - NasdaqWhy iBio Stock Soared Today - Nasdaq
nasdaq.com - May 5 at 11:00 PM
Health Care Sector Update for 05/05/2021: CYRX,CHMA,IBIO,COCP - NasdaqHealth Care Sector Update for 05/05/2021: CYRX,CHMA,IBIO,COCP - Nasdaq
nasdaq.com - May 5 at 5:59 PM
Health Care Sector Update for 05/05/2021: CHMA,IBIO,COCP - NasdaqHealth Care Sector Update for 05/05/2021: CHMA,IBIO,COCP - Nasdaq
nasdaq.com - May 5 at 4:04 PM
A Couple Key Levels To Watch In iBios Stock - BenzingaA Couple Key Levels To Watch In iBio's Stock - Benzinga
benzinga.com - May 5 at 4:04 PM
Regional Health Properties, Chiasma leads healthcare gainers; Cocrystal Pharma, Esperion Therapeutics among major losers - Seeking AlphaRegional Health Properties, Chiasma leads healthcare gainers; Cocrystal Pharma, Esperion Therapeutics among major losers - Seeking Alpha
seekingalpha.com - May 5 at 12:59 PM
Why Nemaura, iBio And Cocrystal Are Moving Wednesday - BenzingaWhy Nemaura, iBio And Cocrystal Are Moving Wednesday - Benzinga
benzinga.com - May 5 at 12:59 PM
DateCompanyBrokerageAction
4/16/2021Oncternal TherapeuticsHC WainwrightReiterated Rating
4/13/2021Oncternal TherapeuticsOppenheimerInitiated Coverage
3/30/2021Oncternal TherapeuticsBrookline Capital ManagementReiterated Rating
3/30/2021Oncternal TherapeuticsBrookline Capital AcquisitionInitiated Coverage
2/23/2021Oncternal TherapeuticsNorthland SecuritiesInitiated Coverage
10/27/2020ImmunomeChardan CapitalInitiated Coverage
10/26/2020ImmunomeLADENBURG THALM/SH SHInitiated Coverage
3/30/2021Wave Life SciencesTruistLower Price Target
3/30/2021Wave Life SciencesSVB LeerinkLower Price Target
3/30/2021Wave Life SciencesMizuhoLower Price Target
3/30/2021Wave Life SciencesRoyal Bank of CanadaLower Price Target
12/31/2019Wave Life SciencesSunTrust BanksReiterated Rating
12/17/2019Wave Life SciencesGuggenheimLower Price Target
12/16/2019Wave Life SciencesCowenReiterated Rating
1/21/2021iBioCantor FitzgeraldInitiated Coverage
11/18/2020iBioAlliance Global PartnersLower Price Target
(Data available from 5/8/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.